154 related articles for article (PubMed ID: 9300354)
1. On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.
Sun H; Ette EI; Ludden TM
J Pharmacokinet Biopharm; 1996 Dec; 24(6):637-50. PubMed ID: 9300354
[TBL] [Abstract][Full Text] [Related]
2. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
Mu S; Ludden TM
J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
[TBL] [Abstract][Full Text] [Related]
3. Balanced designs in longitudinal population pharmacokinetic studies.
Ette EI; Sun H; Ludden TM
J Clin Pharmacol; 1998 May; 38(5):417-23. PubMed ID: 9602953
[TBL] [Abstract][Full Text] [Related]
4. Ignorability and parameter estimation in longitudinal pharmacokinetic studies.
Ette EI; Sun H; Ludden TM
J Clin Pharmacol; 1998 Mar; 38(3):221-6. PubMed ID: 9549660
[TBL] [Abstract][Full Text] [Related]
5. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
Knights J; Rohatagi S
J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
[TBL] [Abstract][Full Text] [Related]
6. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
[TBL] [Abstract][Full Text] [Related]
7. Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
Ishida K; Kayano Y; Taguchi M; Hashimoto Y
Biol Pharm Bull; 2007 Nov; 30(11):2159-62. PubMed ID: 17978492
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.
Ette EI; Kelman AW; Howie CA; Whiting B
Ann Pharmacother; 1993 Sep; 27(9):1034-9. PubMed ID: 8117353
[TBL] [Abstract][Full Text] [Related]
9. Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies.
Ette EI; Howie CA; Kelman AW; Whiting B
Pharm Res; 1995 May; 12(5):729-37. PubMed ID: 7479560
[TBL] [Abstract][Full Text] [Related]
10. Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling.
Jaber MM; Brundage RC
J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):123-132. PubMed ID: 36617366
[TBL] [Abstract][Full Text] [Related]
11. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
Ette EI; Onyiah LC
Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
[TBL] [Abstract][Full Text] [Related]
12. Experimental design and efficient parameter estimation in population pharmacokinetics.
al-Banna MK; Kelman AW; Whiting B
J Pharmacokinet Biopharm; 1990 Aug; 18(4):347-60. PubMed ID: 2231324
[TBL] [Abstract][Full Text] [Related]
13. Analysis of animal pharmacokinetic data: performance of the one point per animal design.
Ette EI; Kelman AW; Howie CA; Whiting B
J Pharmacokinet Biopharm; 1995 Dec; 23(6):551-66. PubMed ID: 8733946
[TBL] [Abstract][Full Text] [Related]
14. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
15. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
Tod M; Aouimer A; Petitjean O
Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.
Hénin E; Tod M; Trillet-Lenoir V; Rioufol C; Tranchand B; Girard P
Clin Pharmacokinet; 2009; 48(6):359-69. PubMed ID: 19650675
[TBL] [Abstract][Full Text] [Related]
17. A note on population pharmacokinetic studies with a single sampling design.
Narukawa M; Yafune A
Ther Drug Monit; 2005 Apr; 27(2):111-5. PubMed ID: 15795638
[TBL] [Abstract][Full Text] [Related]
18. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
Ling J; Qian LX; Ding JJ; Jiao Z
Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.
Tod M; Rocchisani JM
J Pharmacokinet Biopharm; 1997 Aug; 25(4):515-37. PubMed ID: 9561492
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.
White DB; Walawander CA; Tung Y; Grasela TH
J Pharmacokinet Biopharm; 1991 Feb; 19(1):87-112. PubMed ID: 2023111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
